These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 24961498)

  • 1. Prediction of kinase inhibitor response using activity profiling, in vitro screening, and elastic net regression.
    Tran TP; Ong E; Hodges AP; Paternostro G; Piermarocchi C
    BMC Syst Biol; 2014 Jun; 8():74. PubMed ID: 24961498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined kinome inhibition states are predictive of cancer cell line sensitivity to kinase inhibitor combination therapies.
    Joisa CU; Chen KA; Beville S; Stuhlmiller T; Berginski ME; Okumu D; Golitz BT; East MP; Johnson GL; Gomez SM
    Pac Symp Biocomput; 2024; 29():276-290. PubMed ID: 38160286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined kinome inhibition states are predictive of cancer cell line sensitivity to kinase inhibitor combination therapies.
    Joisa CU; Chen KA; Beville S; Stuhlmiller T; Berginski ME; Okumu D; Golitz BT; Johnson GL; Gomez SM
    bioRxiv; 2023 Aug; ():. PubMed ID: 37577663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A kinase inhibition map approach for tumor sensitivity prediction and combination therapy design for targeted drugs.
    Pal R; Berlow N
    Pac Symp Biocomput; 2012; ():351-62. PubMed ID: 22174290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic Profiling and Evaluation of Structure-based Kinase-Inhibitor Interactome in Cervical Cancer by Integrating In Silico Analyses and In Vitro Assays at Molecular and Cellular Levels.
    Zhu LX; Liu Q; Hua YF; Yang N; Zhang XG; Ding X
    Comput Biol Chem; 2019 Jun; 80():324-332. PubMed ID: 31078911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presence and utility of intrinsically disordered regions in kinases.
    Kathiriya JJ; Pathak RR; Clayman E; Xue B; Uversky VN; Davé V
    Mol Biosyst; 2014 Nov; 10(11):2876-88. PubMed ID: 25099472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of selective cytotoxic and synthetic lethal drug responses in triple negative breast cancer cells.
    Gautam P; Karhinen L; Szwajda A; Jha SK; Yadav B; Aittokallio T; Wennerberg K
    Mol Cancer; 2016 May; 15(1):34. PubMed ID: 27165605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DIFFERENTIAL PATHWAY DEPENDENCY DISCOVERY ASSOCIATED WITH DRUG RESPONSE ACROSS CANCER CELL LINES.
    Speyer G; Mahendra D; Tran HJ; Kiefer J; Schreiber SL; Clemons PA; Dhruv H; Berens M; Kim S
    Pac Symp Biocomput; 2017; 22():497-508. PubMed ID: 27897001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated single-dose kinome profiling data is predictive of cancer cell line sensitivity to kinase inhibitors.
    Joisa CU; Chen KA; Berginski ME; Golitz BT; Jenner MR; Herrera Loeza G; Yeh JJ; Gomez SM
    PeerJ; 2023; 11():e16342. PubMed ID: 38025707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in designing substrate-competitive protein kinase inhibitors.
    Han KC; Kim SY; Yang EG
    Curr Pharm Des; 2012; 18(20):2875-82. PubMed ID: 22571656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioinformatic mining of kinase inhibitors that regulate autophagy through kinase signaling pathways.
    Yang Y; Ma B; Jin Y; Ben W; Zhang D; Jiang K; Feng S; Huang L; Zheng J
    Mol Med Rep; 2014 Dec; 10(6):3348-56. PubMed ID: 25323421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. INTEGRATING GENETIC AND STRUCTURAL DATA ON HUMAN PROTEIN KINOME IN NETWORK-BASED MODELING OF KINASE SENSITIVITIES AND RESISTANCE TO TARGETED AND PERSONALIZED ANTICANCER DRUGS.
    Verkhivker GM
    Pac Symp Biocomput; 2016; 21():45-56. PubMed ID: 26776172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinome inhibition states and multiomics data enable prediction of cell viability in diverse cancer types.
    Berginski ME; Joisa CU; Golitz BT; Gomez SM
    PLoS Comput Biol; 2023 Feb; 19(2):e1010888. PubMed ID: 36809237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leveraging Structural Diversity and Allosteric Regulatory Mechanisms of Protein Kinases in the Discovery of Small Molecule Inhibitors.
    Verkhivker GM
    Curr Med Chem; 2017; 24(42):4838-4872. PubMed ID: 27719654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profile-QSAR: a novel meta-QSAR method that combines activities across the kinase family to accurately predict affinity, selectivity, and cellular activity.
    Martin E; Mukherjee P; Sullivan D; Jansen J
    J Chem Inf Model; 2011 Aug; 51(8):1942-56. PubMed ID: 21667971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multitask learning improves prediction of cancer drug sensitivity.
    Yuan H; Paskov I; Paskov H; González AJ; Leslie CS
    Sci Rep; 2016 Aug; 6():31619. PubMed ID: 27550087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinase inhibitor library screening identifies synergistic drug combinations effective in sensitive and resistant melanoma cells.
    Margue C; Philippidou D; Kozar I; Cesi G; Felten P; Kulms D; Letellier E; Haan C; Kreis S
    J Exp Clin Cancer Res; 2019 Feb; 38(1):56. PubMed ID: 30728057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.
    Gao Y; Davies SP; Augustin M; Woodward A; Patel UA; Kovelman R; Harvey KJ
    Biochem J; 2013 Apr; 451(2):313-28. PubMed ID: 23398362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular subtyping of cancer and nomination of kinase candidates for inhibition with phosphoproteomics: Reanalysis of CPTAC ovarian cancer.
    Tong M; Yu C; Zhan D; Zhang M; Zhen B; Zhu W; Wang Y; Wu C; He F; Qin J; Li T
    EBioMedicine; 2019 Feb; 40():305-317. PubMed ID: 30594550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivo.
    Signore M; Pelacchi F; di Martino S; Runci D; Biffoni M; Giannetti S; Morgante L; De Majo M; Petricoin EF; Stancato L; Larocca LM; De Maria R; Pallini R; Ricci-Vitiani L
    Cell Death Dis; 2014 May; 5(5):e1223. PubMed ID: 24810059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.